Works matching IS 15268209 AND DT 2023 AND VI 23 AND IP 2
Results: 14
Is Sentinel Lymph Node Biopsy Necessary in Patients who Undergo Prophylactic Mastectomy?
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 2, p. 231, doi. 10.1016/j.clbc.2022.12.003
- By:
- Publication type:
- Article
Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [<sup>99m</sup>Tc] Tc-Labeled Small Peptide.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 2, p. 219, doi. 10.1016/j.clbc.2022.12.002
- By:
- Publication type:
- Article
Insurance Coverage of Prophylactic Mastectomies: A National Review of the United States.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 2, p. 211, doi. 10.1016/j.clbc.2022.12.001
- By:
- Publication type:
- Article
AMACR Expression is a Potential Diagnostic Marker in Apocrine Lesions of Breast, and is Associated with High Histologic Grade and Lymph Node Metastases in Some Invasive Apocrine Breast Cancers.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 2, p. 199, doi. 10.1016/j.clbc.2022.11.012
- By:
- Publication type:
- Article
Downregulated miR-367-3p, miR-548aq-5p, and miR-4710 in Human Whole Blood: Potential Biomarkers for Breast Cancer With Axillary Lymph Node Metastasis.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 2, p. 189, doi. 10.1016/j.clbc.2022.11.011
- By:
- Publication type:
- Article
The Impact of Limited Language Proficiency in Screening for Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 2, p. 181, doi. 10.1016/j.clbc.2022.11.008
- By:
- Publication type:
- Article
Early Toxicity and Patient-Reported Cosmetic Outcomes in Patients Treated With Adjuvant Proton-Based Radiotherapy After Breast-Conserving Surgery.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 2, p. 176, doi. 10.1016/j.clbc.2022.11.009
- By:
- Publication type:
- Article
USP22 Contributes to Chemoresistance, Stemness, and EMT Phenotype of Triple-Negative Breast Cancer Cells by egulating the Warburg Effect via c-Myc Deubiquitination.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 2, p. 162, doi. 10.1016/j.clbc.2022.11.006
- By:
- Publication type:
- Article
Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 2, p. 155, doi. 10.1016/j.clbc.2022.11.005
- By:
- Publication type:
- Article
Circ_0001777 Affects Triple-negative Breast Cancer Progression Through the miR-95-3p/AKAP12 Axis.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 2, p. 143, doi. 10.1016/j.clbc.2022.11.004
- By:
- Publication type:
- Article
COVID-19 Incidence and Mortality in Patients Operated on for Breast Cancer. Comparison with the General Population.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 2, p. 135, doi. 10.1016/j.clbc.2022.11.002
- By:
- Publication type:
- Article
Investigation of mRNA Expression Levels of Tip60 and Related DNA Repair Genes in Molecular Subtypes of Breast Cancer.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Diagnostic Performance of PET/MRI in Breast Cancer: A Systematic Review and Bayesian Bivariate Meta-analysis.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 2, p. 108, doi. 10.1016/j.clbc.2022.11.010
- By:
- Publication type:
- Article
Experiences of Women With Breast Cancer Using Telehealth: A Qualitative Systematic Review.
- Published in:
- 2023
- By:
- Publication type:
- journal article